Skip to content

Idylla™ KRAS Mutation Test

by Biocartis NV

Ref A0020/6Model Idylla™ KRAS Mutation Test

Idylla KRAS Mutation Test (A0020/6) is an in vitro diagnostic device (EU IVDD general IVD; EMDN category K-ras) made by Biocartis NV, registered in EUDAMED on 5 Nov 2026 (Basic UDI-DI B-15415219000512), active as of 7 Nov 2026.

Active European Union

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-15415219000512 Basic UDI-DI 15415219000512UDI-DIDate5 Nov 2026RegisteredStatusActive

Official records

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDD Active

Specification

EUDAMED

Model / reference
Idylla™ KRAS Mutation Test, A0020/6
Primary DI / UDI-DI
15415219000512
Basic UDI-DI
B-15415219000512
EMDN code
W01060202 K-ras
Device class
Class IVD General
EU registration type
Legacy device (under a directive)
EU market of registration
Belgium

Manufacturer details

EUDAMED SRN
BE-MF-000003661

Similar devices in this category

Other devices filed under ACQUIRED GENE OR CHROMOSOME ALTERATIONS.

Other devices from Biocartis NV

See all devices from Biocartis NV →

Properties

  • Reagent
  • Professional testing
Other properties (10, all answered No)